ECNP Podcast series

The building of an academic career can be a beautiful but challenging road. Anna Beyeler, France, is a principal investigator at the French Institute of Health (INSERM). In this podcast, Ilse Graat, the Netherlands, talks with her about the ups and downs of her academic career path and how she currently helps early career scientists in building their own career. Amongst other things, she highlights that there should be more attention for the full range of neuroscience careers, not only emphasizing careers in Academia.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

The PRISM 2 project aims to develop a quantitative biological approach to the understanding of neuropsychiatric diseases. In this episode Abi Abrahams interviews Professor Martien Kas and Dr. Hugh Marston, where they discussed the aims and legacy of the PRISM 2 project. Conversation covered areas such as industry and academia collaboration, advice for early career scientists, and their hopes for the future in the field of neuropsychiatry.

Important links:
Prism 2 project: https://prism2-project.eu/en/prism-study/
Innovative Medicine Initiative: https://www.imi.europa.eu/

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Lived experience experts bring unique insights and perspectives to the research process. In this podcast, Vanessa Pinfold, United Kingdom, and Annemiek van Berkel, The Netherlands, discuss how to truly engage lived experience in research. As research director at the McPin Foundation, Vanessa has over a decade experience on how to put lived experience at the core of mental health research. She shares strategies and practical tips on how to ensure meaningful involvement - especially for those who would like to start but unsure how. Join this insightful conversation and get inspired!

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this podcast, pharmacologist Christina Dalla, shares with Aiste Lengvenyte, France, her journey into the world of sex differences in depression models and antidepressant response. They discuss why sex matters in neuroscience and how it should be integrated into research. Christina also shares the challenges and rewards of her career and gives insight into the role of sex and gender in the future of applied neuroscience.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

We are more prosperous, but mentally sicker than ever. Does prosperity bring bad luck? In this podcast Damiaan Denys and Ilse Graat discuss the paradox between greater economic wealth and the increase of mental complaints. Additionally, Damiaan talks about the choices he made as an early career researcher, his professional journey and his reasons to combine philosophy, psychiatry, clinical work and scientific research. One of his research topics focusses on confidence, in this podcast he explains that confidence abnormalities are associated with different psychiatric disorders. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

The COVID pandemic created a beneficial momentum in mental health research. In this podcast, Celso Arango and Aiste Lengvenyte discuss the challenges in youth mental health including awareness, prevention and access to treatment. They also talk about the latest discoveries on the causes of neurodevelopmental conditions and the need for a more dimensional approach in mental health. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

The use of psychedelics in the treatment of psychiatric disorders has been receiving widespread attention from the nonprofessional and scientific community for the last few years. The practice of taking a small, non-psychedelic dose of LSD or psilocybin to improve particular behaviour, emotions, or a psychiatric condition is claimed to be effective by its users. In this podcast Ilse Graat, the Netherlands, interviews Kim Kuypers, the Netherlands, on her path towards psychedelics, discussing where this young research field stands and where it is heading, including new research on microdosing yet to be explored.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Would you like to know ‘why we just don’t do the things we know are good for us?’ listen to part two of the podcast series with Silke Matura and Veerle van Gils. Learn more on the effects of lifestyle on cognition and get familiar with the various techniques used to measure different types of cognition. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In part one of the two-part podcast series, recorded during the ECNP Congress in Vienna, PhD student Veerle van Gils and senior clinical scientist and psychologist Dr Silke Matura discuss the role of dysfunctional insulin signalling as modulator of mental and non-mental chronic diseases. They are both part of the PRIME (Prevention and Remediation of Insulin Multimorbidity in Europe) project trying to identify and specify the molecular mechanisms underlying insulin comorbidities. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this podcast Andreas Reif, past-chair of the Scientific Programme Committee, is in conversation with Early Career Advisory Panel chair Nils Opel. Andreas Reif, who studies molecular underpinnings of neuropsychiatric disorders, talks about his life in science and how science has speeded up since he started his career. In addition, he shares some advice to ensure a successful career start, elaborates on his participation in research networks and the impact of the COVID19 pandemic on research and mental health 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.